Lymphocutaneous Sporotrichosis Refractory to First-Line Treatment
Author(s) -
Walter Belda,
Luiz Felipe Domingues Passero,
Ana Thereza Stradioto Casolato
Publication year - 2021
Publication title -
case reports in dermatological medicine
Language(s) - English
Resource type - Journals
eISSN - 2090-6471
pISSN - 2090-6463
DOI - 10.1155/2021/9453701
Subject(s) - sporotrichosis , itraconazole , sporothrix schenckii , medicine , amphotericin b , terbinafine , iodine , mycosis , refractory (planetary science) , dermatology , dimorphic fungus , surgery , antifungal , biology , materials science , genetics , astrobiology , metallurgy , yeast
Sporotrichosis is a fungal infection endemic in Latin America and has been attributed to the thermodimorphic fungus of the genus Sporothrix . Transmission to humans occurs during a traumatic injury with soil or organic material; additionally, lesions caused by infected cats play an important role in the epidemiology of the disease. The classic treatment of sporotrichosis is performed with itraconazole or potassium iodide; second-line medications, such as amphotericin B and terbinafine, can alternatively be used in cases of first-line drug failure. In the present study, a patient with lymphocutaneous sporotrichosis in the right upper limb exhibited intolerance to itraconazole and potassium iodide, additionally during the period of use; these drugs did not control skin lesions. In this patient, amphotericin B deoxycholate and its liposomal version were used in this patient; and complete recovery of the lesions was observed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom